Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training.
Pilchová V, Prajeeth CK, Jendrny P, Twele F, Meller S, Pink I, Fathi A, Addo MM, Volk HA, Osterhaus A, von Köckritz-Blickwede M, Schulz C. Pilchová V, et al. Among authors: prajeeth ck. J Virol Methods. 2023 Jul;317:114733. doi: 10.1016/j.jviromet.2023.114733. Epub 2023 Apr 15. J Virol Methods. 2023. PMID: 37068591 Free PMC article. Review.
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial.
Leroux-Roels I, Prajeeth CK, Aregay A, Nair N, Rimmelzwaan GF, Osterhaus ADME, Kardinahl S, Pelz S, Bauer S, D'Onofrio V, Alhatemi A, Jacobs B, De Boever F, Porrez S, Waerlop G, Punt C, Hendriks B, von Mauw E, van de Water S, Harders-Westerveen J, Rockx B, van Keulen L, Kortekaas J, Leroux-Roels G, Wichgers Schreur PJ. Leroux-Roels I, et al. Among authors: prajeeth ck. Lancet Infect Dis. 2024 Nov;24(11):1245-1253. doi: 10.1016/S1473-3099(24)00375-X. Epub 2024 Jul 25. Lancet Infect Dis. 2024. PMID: 39068957 Clinical Trial.
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.
Prajeeth CK, Zdora I, Saletti G, Friese J, Gerlach T, Wilken L, Beicht J, Kubinski M, Puff C, Baumgärtner W, Kortekaas J, Wichgers Schreur PJ, Osterhaus ADME, Rimmelzwaan GF. Prajeeth CK, et al. Emerg Microbes Infect. 2024 Dec;13(1):2373313. doi: 10.1080/22221751.2024.2373313. Epub 2024 Jul 10. Emerg Microbes Infect. 2024. PMID: 38946528 Free PMC article.
Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.
Beicht J, Kubinski M, Zdora I, Puff C, Biermann J, Gerlach T, Baumgärtner W, Sutter G, Osterhaus ADME, Prajeeth CK, Rimmelzwaan GF. Beicht J, et al. Among authors: prajeeth ck. Front Immunol. 2023 Jul 7;14:1177324. doi: 10.3389/fimmu.2023.1177324. eCollection 2023. Front Immunol. 2023. PMID: 37483628 Free PMC article.
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection.
Kubinski M, Beicht J, Zdora I, Biermann J, Puff C, Gerlach T, Tscherne A, Baumgärtner W, Osterhaus ADME, Sutter G, Prajeeth CK, Rimmelzwaan GF. Kubinski M, et al. Among authors: prajeeth ck. Front Immunol. 2023 Apr 21;14:1182963. doi: 10.3389/fimmu.2023.1182963. eCollection 2023. Front Immunol. 2023. PMID: 37153588 Free PMC article.
Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection.
Kubinski M, Beicht J, Zdora I, Saletti G, Kircher M, Petry-Gusmag M, Steffen I, Puff C, Jung K, Baumgärtner W, Rimmelzwaan GF, Osterhaus ADME, Prajeeth CK. Kubinski M, et al. Among authors: prajeeth ck. Front Immunol. 2023 Feb 28;14:1134371. doi: 10.3389/fimmu.2023.1134371. eCollection 2023. Front Immunol. 2023. PMID: 36926332 Free PMC article.
34 results